Literature DB >> 27031291

MicroRNA-495 Regulates Migration and Invasion in Prostate Cancer Cells Via Targeting Akt and mTOR Signaling.

Jian-Zhang Li1, Zhen-Long Wang2, Wan-Hai Xu1, Qing Li1, Lin Gao1, Zi-Ming Wang2.   

Abstract

Abnormal microRNA (miR) expressions were implicated in prostate cancer progression. We identified a novel miR-495, which was downregulated in prostate cancer, but not normal prostate cell lines. MiR-495 directly targeted the 3'-UTR of Akt and mTOR mRNAs. Expression of miR-495 in prostate cancer cells significantly downregulated Akt and mTOR, which further inhibited cancer cell proliferation, migration, and invasion in vitro. Function of miR-495 in vivo was examined in mouse xenograft model and was found to significantly inhibit the growth of tumors, mediated by repressing Akt and mTOR. Our report supported miR-495 as a novel tumor suppressor microRNA in prostate cancer.

Entities:  

Keywords:  Akt; Mammalian target of rapamycin (mTOR); MicroRNA-495; Prostate cancer; Tumorigenesis

Mesh:

Substances:

Year:  2016        PMID: 27031291     DOI: 10.3109/07357907.2016.1156690

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  10 in total

1.  Long non-coding RNA NORAD exhaustion represses prostate cancer progression through inhibiting TRIP13 expression via competitively binding to miR-495-3p.

Authors:  Fengling Chen; Ling Liu; Shuya Wang
Journal:  Cancer Cell Int       Date:  2020-07-18       Impact factor: 5.722

2.  MicroRNA-495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin-like growth factor receptor-1.

Authors:  Ying Ye; Juhua Zhuang; Guangdong Wang; Saifei He; Suiliang Zhang; Guoyu Wang; Jing Ni; Jiening Wang; Wei Xia
Journal:  Exp Ther Med       Date:  2017-11-08       Impact factor: 2.751

Review 3.  Targeting MicroRNAs in Cancer Gene Therapy.

Authors:  Weidan Ji; Bin Sun; Changqing Su
Journal:  Genes (Basel)       Date:  2017-01-09       Impact factor: 4.096

4.  miR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression.

Authors:  Zhenyou Zou; Ruyi Zou; Dan Zong; Yonghong Shi; Jinyao Chen; Jie Huang; Jiahui Zhu; Liguan Chen; Xiaoyan Bao; Yuan Liu; Weihao Liu; Wenhui Huang; Jingsang Hu; Zhi Chen; Xiaojie Lao; Chaoqun Chen; Xiaoli Huang; Yao Lu; Xueyin Ni; Daoquan Fang; Dengqiang Wu; Shuangshuang Lu; Mingzhu Jiang; Chenyang Qiu; Yuya Wu; Qisha Qiu; Yanyuan Dong; Yangyang Su; Chenmin Zhao; Zhihe Zhong; Jing Cai; Yong Liang
Journal:  J Cell Mol Med       Date:  2017-04-14       Impact factor: 5.310

Review 5.  Dysregulation of ncRNAs located at the DLK1‑DIO3 imprinted domain: involvement in urological cancers.

Authors:  Jiangfeng Li; Haixiang Shen; Haiyun Xie; Yufan Ying; Ke Jin; Huaqing Yan; Song Wang; Mingjie Xu; Xiao Wang; Xin Xu; Liping Xie
Journal:  Cancer Manag Res       Date:  2019-01-15       Impact factor: 3.989

6.  Genome-wide analysis to identify a novel microRNA signature that predicts survival in patients with stomach adenocarcinoma.

Authors:  Shan-Shan Luo; Xi-Wen Liao; Xiao-Dong Zhu
Journal:  J Cancer       Date:  2019-10-17       Impact factor: 4.207

7.  Adhesion of monocytes and endothelial cells isolated from the human aorta suppresses by miRNA-PEI particles.

Authors:  Adeleh Poursaleh; Farnaz Sadegh Beigee; Golnaz Esfandiari; Mohammad Najafi
Journal:  BMC Cardiovasc Disord       Date:  2021-08-16       Impact factor: 2.298

8.  Detection of Extracellular Vesicle RNA Using Molecular Beacons.

Authors:  Getulio Pereira de Oliveira; Eric Zigon; Gaenna Rogers; Danny Davodian; Shulin Lu; Tijana Jovanovic-Talisman; Jennifer Jones; John Tigges; Sanjay Tyagi; Ionita Calin Ghiran
Journal:  iScience       Date:  2019-12-19

9.  Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression.

Authors:  Chen Du; Caihong Lv; Yue Feng; Siwen Yu
Journal:  J Exp Clin Cancer Res       Date:  2020-10-21

10.  Long non‑coding RNA SNHG20 promotes colorectal cancer cell proliferation, migration and invasion via miR‑495/STAT3 axis.

Authors:  Yu Wang; Jianying Fu; Lili Yang; Zhi Liang
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.